A randomised, double-blind, phase III study comparing SB2, an infliximab biosimilar, to the infliximab reference product Remicade in patients with moderate to severe rheumatoid arthritis despite methotrexate therapy
| Image |  |
|---|---|
| Description | scientific article published on 28 August 2015 |
| Author/s |
author: Hana Ciferská Roman Yatsyshyn |
| Publication date | August 28, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |